DENALI THERAPEUTICS INC. (DNLI)
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
One Stop Systems Announces the Appointment of Paul Averna as Vice President Business Development and Growth
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
BRIXMOR PROPERTY GROUP ISSUES ANNUAL CORPORATE RESPONSIBILITY REPORT
Net Asset Value(s)
May 2026 Monthly Release
Net Asset Value(s)
Norwood Financial Corp Announces Cash Dividend